Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
According to a filing submitted to the U.S. Securities and Exchange Commission (SEC), Karyopharm Therapeutics Inc. has obtained permission through an amended agreement to defer the payment deadline for certain amounts until September 2026.

According to a filing submitted to the U.S. Securities and Exchange Commission (SEC), Karyopharm Therapeutics Inc. has obtained permission through an amended agreement to defer the payment deadline for certain amounts until September 2026.

老虎证券老虎证券2026/03/03 11:29
Show original
This arrangement provides the company with more flexible financial operational space.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!